Literature DB >> 17425300

Identifying promising compounds in drug discovery: genetic algorithms and some new statistical techniques.

Abhyuday Mandal1, Kjell Johnson, C F Jeff Wu, Dirk Bornemeier.   

Abstract

Throughout the drug discovery process, discovery teams are compelled to use statistics for making decisions using data from a variety of inputs. For instance, teams are asked to prioritize compounds for subsequent stages of the drug discovery process, given results from multiple screens. To assist in the prioritization process, we propose a desirability function to account for a priori scientific knowledge; compounds can then be prioritized based on their desirability scores. In addition to identifying existing desirable compounds, teams often use prior knowledge to suggest new, potentially promising compounds to be created in the laboratory. Because the chemistry space to search can be dauntingly large, we propose the sequential elimination of level combinations (SELC) method for identifying new optimal compounds. We illustrate this method on a combinatorial chemistry example.

Mesh:

Year:  2007        PMID: 17425300     DOI: 10.1021/ci600556v

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  3 in total

1.  Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.

Authors:  Travis T Wager; Xinjun Hou; Patrick R Verhoest; Anabella Villalobos
Journal:  ACS Chem Neurosci       Date:  2010-03-25       Impact factor: 4.418

2.  Quantifying the chemical beauty of drugs.

Authors:  G Richard Bickerton; Gaia V Paolini; Jérémy Besnard; Sorel Muresan; Andrew L Hopkins
Journal:  Nat Chem       Date:  2012-01-24       Impact factor: 24.427

3.  Data-driven desirability function to measure patients' disease progression in a longitudinal study.

Authors:  Hsiu-Wen Chen; Weng Kee Wong; Hongquan Xu
Journal:  J Appl Stat       Date:  2015-10-09       Impact factor: 1.404

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.